GSK whistleblowers handsomely rewarded for their evidence which helped in the US prosecution of Glaxo for drug mispromotion and fraud

The Telegraph reports that four former GlaxoSmithKline employees will share up to £159 million for their part in the successful prosecution of the drug company. Unfortunately Glaxo's crimes and misdemeanours are regarded with amazing leniency in Britain, as evidenced by the award of a knighthood earlier this year to Andrew Witty, CEO of GlaxoSmithKline. Drug company profits trump patient safety and corporate ethics.